In clinical trials, drug and kit demand is highly volatile, driven by patient enrollment velocity and visit schedules. Manual forecasting, often lagging by weeks, cannot react to a site enrolling five patients in a day or a protocol amendment. This disconnect creates two costly failures: critical stockouts that stall patient dosing and waste from expired specialty drugs, eroding trial budgets and timelines. The operational bottleneck is the lack of a real-time, automated link between enrollment data and supply chain execution.




